News
-
-
-
-
-
-
-
-
PRESS RELEASE
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
ONWARD Medical reports successful Q3 2025 with 40 ARC-EX Systems sold, regulatory milestones achieved, science & tech advancements highlighted, and record revenue surpassing EUR 1 million -
-
PRESS RELEASE
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
ONWARD Medical N.V. announces groundbreaking advancements in blood pressure regulation after Spinal Cord Injury with ARC-IM Therapy, supported by clinical evidence in Nature and Nature Medicine